Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news

Show

From To
IPM Receives £15 Million from UK Government to Advance Innovative Health Products for Women

Funding will accelerate development of HIV prevention tools and other sexual and reproductive health technologies.

Published
22 August 2013
From
International Partnership for Microbicides
New prevention strategies will only be implemented if they are tailored to local contexts and cultures

While clinical trials have demonstrated the efficacy of treatment as prevention, pre-exposure prophylaxis and vaginal microbicides, researchers and policy makers lack clarity on the conditions that affect

Published
20 June 2013
By
Roger Pebody
Disappointing tenofovir PrEP trials: maybe “adherence” is not to blame

Reports of modest success from two trials (2010) of tenofovir as pre-exposure prophylaxis against HIV (PrEP)– CAPRISA 004 (1) (topical gel/women) relative risk reduction (RRR) 39%; iPrEX (2) (oral tablet/MSM) RRR 44% – have inspired recent contributions to STI journal.

Published
29 March 2013
From
BMJ Group blogs
Testing HIV Prevention Tools: Other Ways Up the Alley

We need to design prevention trials that ask, “Is this test product better than nothing?” rather than, “Is this test product better than the best available prevention combination we have?”

Published
15 March 2013
From
Poz
Mitchell Warren: Listening to Women's Voices on HIV Prevention

The VOICE trial results show that we still have a lot to learn about what women really want and need in HIV prevention. The women in the trial are telling us something that is true for every group at risk for HIV: to help more people avoid infection, we need to offer prevention tools they will actually want, demand and use.

Published
12 March 2013
From
Huffington Post
Bee Venom Destroys HIV And Spares Surrounding Cells

Nanoparticles containing bee venom toxin melittin can destroy human immunodeficiency virus (HIV) while at the same time leaving surrounding cells unharmed, scientists from Washington University School of Medicine reported in the March 2013 issue of Antiviral Therapy.

Published
10 March 2013
From
HIV / AIDS News From Medical News Today
CROI 2013: The VOICE Results—A Social Scientist’s Perspective

To social scientist Judith D. Auerbach, PhD, a consultant to the NIH Office of AIDS Research and San Francisco AIDS Foundation, the VOICE results raise a number of questions—but not the ones you might think.

Published
06 March 2013
From
BETA blog
After VOICE trial, question remains: What were women telling researchers?

The results were disappointing in every way: the products evaluated were not shown to be effective, the adherence to using the products was dismal – and cancelling the possibility of learning if the products conferred any protection, it was worst among the demographic at highest risk — the younger, unmarried women.

Published
05 March 2013
From
Science Speaks
Statements on the VOICE results

Comments on the disappointing vaginal microbicide and PrEP results from AVAC, the Gates Foundation, the NIH, and others.

Published
05 March 2013
From
AVAC
Monthly injectable drug offers 100% protection against HIV in monkeys – could be dosed every three months

An injectable, long-lasting integrase inhibitor drug, when given to rhesus macaques exposed to a monkey-adapted version of HIV, completely protected them against the virus. This drug, an injectable

Published
04 March 2013
By
Gus Cairns

Filter by country